Keyword [rational drug design]
Result: 1 - 20 | Page: 1 of 2 |
| 1. | The Design, Synthesis, Biological Evaluations And QSAR Studies Of Emodin Derivatives Targeted At MMPs |
| 2. | Design, Synthesis And Preliminary Evaluation Of Matrix Metalloproteinase-2 Inhibitors Based On Pyrrolidine Scaffold |
| 3. | Design And Synthesis Of Novel VEGF Receptor Inhibitors |
| 4. | Synthesis And Anticancer Activity Study Of Bioactive Natural Products And Their Derivatives |
| 5. | Design, Synthesis And Activity Study Of L-Arginine Derivatives As Aminopeptidase N Inhibitors |
| 6. | The Synthesis And Activity Assay Of Tartaric Acid Derivatives As AminopeptidaseN Inhibitors |
| 7. | Rational Drug Design On DPP4 And PTP1B Related To Type â…¡ Diabetes Mellitus |
| 8. | Design, Synthesis And Preliminary Activity Assay Of Pyrrolidines MMPIs |
| 9. | The Design, Synthesis And Preliminary Activity Assay In Vitro Of AHPA Derivatives As APN Inhibitors |
| 10. | The Design, Synthesis And Preliminary Activity Assay In Vitro Of L-iso-Glutamine Derivatives As APN Inhibitors |
| 11. | Design And Synthesis Of Matrix Metalloproteinases-2,9 Inhibitors Based On Computer-Aided Drug Design |
| 12. | Design, Synthesis And Preliminary Activity Assay In Vitro Of L-Lysine Derivatives As APN Inhibitors |
| 13. | The Design, Synthesis And Preliminary Activity Assay In Vitro Of L-iso-Glutamine Peptidomimetic Derivatives |
| 14. | The Synthesis And Activity Assay Of AminopeptidaseN Inhibitors |
| 15. | Rational Drug Design Against β3-AR And GLP-1R Related To Type Ⅱ Diabetes Mellitus |
| 16. | Design, Synthesis, Biological Evaluation And SAR Studies Of Sorafenib Derivatives As Potential Antitumor Agents |
| 17. | The Synthesis And Preliminary Activity Assay In Vitro Of Low Molecular Weight Peptide-like Derivatives As APN Inhibitors |
| 18. | Design,Synthesis And Activity Study Of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine Deacetylase(LpxC)Inhibitors As Novel Antibiotic |
| 19. | Synthesis Of Novel Amber Lactam Derivatives As Aminopeptidase N Inhibitors And Preliminary Study On Their Activities In Vitro |
| 20. | Rational Drug Design Of Three GPCRs Related To Neurodegenerative Diseases |
|
